Feedback / Questions
moponetug (BMS-986446) - BMS
Study to Assess Drug Levels, Immune Response, Safety and Tolerability of BMS-986446 in Healthy Chinese Participants.
(clinicaltrials.gov)
-
Oct 2, 2026 -
P1 | N=10 | Not yet recruiting | Sponsor: Bristol-Myers Squibb
New P1 trial
http://clinicaltrials.gov/ct2/show/NCT07852962
Oct 2, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next